Ian J. CONSTABLE,P. Elizabeth RAKOCZY,Chooi-May LAI,Thomas W. CHALBERG
申请号：
US15961654
公开号：
US20180311319A1
申请日:
2018.04.24
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The present disclosure provides compositions and methods for the prevention or treatment of ocular neovascularization, such as AMD, in a human subject, by administering subretinally a pharmaceutical composition comprising a pharmaceutically effective amount of a vector comprising a nucleic acid encoding soluble Fms-related tyrosine kinase-1 (sFlt-1) protein to the human subject.
